Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list

<h4>Objectives</h4> <p>Randomised clinical trials (RCTs) are costly and published information on resource requirements for their conduct is limited. To identify key factors for making RCTs more sustainable, empirical data on resource use and associated costs are needed. We aimed t...

Descripció completa

Dades bibliogràfiques
Autors principals: Speich, B, Von Niederhäusern, B, Blum, CA, Keiser, J, Schur, N, Fürst, T, Kasenda, B, Christ-Crain, M, Hemkens, LG, Pauli-Magnus, C, Schwenkglenks, M, Briel, M
Format: Journal article
Publicat: Elsevier 2017
_version_ 1826305207989960704
author Speich, B
Von Niederhäusern, B
Blum, CA
Keiser, J
Schur, N
Fürst, T
Kasenda, B
Christ-Crain, M
Hemkens, LG
Pauli-Magnus, C
Schwenkglenks, M
Briel, M
author_facet Speich, B
Von Niederhäusern, B
Blum, CA
Keiser, J
Schur, N
Fürst, T
Kasenda, B
Christ-Crain, M
Hemkens, LG
Pauli-Magnus, C
Schwenkglenks, M
Briel, M
author_sort Speich, B
collection OXFORD
description <h4>Objectives</h4> <p>Randomised clinical trials (RCTs) are costly and published information on resource requirements for their conduct is limited. To identify key factors for making RCTs more sustainable, empirical data on resource use and associated costs are needed. We aimed to retrospectively assess resource use and detailed costs of two academic, investigator-initiated RCTs using a comprehensive list of cost items.</p> <h4>Study Desgn and Setting</h4> <p>The resource use of two investigator-initiated RCTs (Prednisone-Trial [NCT00973154] and Oxantel-Trial [ISRCTN54577342]) was empirically assessed in a standardized manner through semi-structured interviews and a systematically developed cost item list. Using information about yearly salaries, resource use was translated into costs. Additionally, we collected all “other costs” including fixed priced items. Overall costs as well as cost of different study phases were calculated.</p> <h4>Results</h4> <p>The personnel time used in the Prednisone-Trial trial was approximately 2,897 working days and the overall costs were calculated to be USD 2.3 million, which was USD 700,000 more than planned. In the Oxantel-Trial 798 working days were spent and the overall costs were as originally planned USD 100,000. Cost drivers were similar between the two RCTs with recruitment delays explaining the additional costs in the Prednisone-Trial.</p> <h4>Conclusion</h4> <p>This case study provides an example of how to transparently assess resources and costs of RCTs, and presents detailed empirical data on type and magnitude of expenses. In the future, this model approach may serve others to plan, assess, or monitor resource use and costs of RCTs.</p>
first_indexed 2024-03-07T06:29:23Z
format Journal article
id oxford-uuid:f5740dd3-0b45-4e7b-8f2e-d4872a6c326c
institution University of Oxford
last_indexed 2024-03-07T06:29:23Z
publishDate 2017
publisher Elsevier
record_format dspace
spelling oxford-uuid:f5740dd3-0b45-4e7b-8f2e-d4872a6c326c2022-03-27T12:27:28ZRetrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item listJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f5740dd3-0b45-4e7b-8f2e-d4872a6c326cSymplectic Elements at OxfordElsevier2017Speich, BVon Niederhäusern, BBlum, CAKeiser, JSchur, NFürst, TKasenda, BChrist-Crain, MHemkens, LGPauli-Magnus, CSchwenkglenks, MBriel, M <h4>Objectives</h4> <p>Randomised clinical trials (RCTs) are costly and published information on resource requirements for their conduct is limited. To identify key factors for making RCTs more sustainable, empirical data on resource use and associated costs are needed. We aimed to retrospectively assess resource use and detailed costs of two academic, investigator-initiated RCTs using a comprehensive list of cost items.</p> <h4>Study Desgn and Setting</h4> <p>The resource use of two investigator-initiated RCTs (Prednisone-Trial [NCT00973154] and Oxantel-Trial [ISRCTN54577342]) was empirically assessed in a standardized manner through semi-structured interviews and a systematically developed cost item list. Using information about yearly salaries, resource use was translated into costs. Additionally, we collected all “other costs” including fixed priced items. Overall costs as well as cost of different study phases were calculated.</p> <h4>Results</h4> <p>The personnel time used in the Prednisone-Trial trial was approximately 2,897 working days and the overall costs were calculated to be USD 2.3 million, which was USD 700,000 more than planned. In the Oxantel-Trial 798 working days were spent and the overall costs were as originally planned USD 100,000. Cost drivers were similar between the two RCTs with recruitment delays explaining the additional costs in the Prednisone-Trial.</p> <h4>Conclusion</h4> <p>This case study provides an example of how to transparently assess resources and costs of RCTs, and presents detailed empirical data on type and magnitude of expenses. In the future, this model approach may serve others to plan, assess, or monitor resource use and costs of RCTs.</p>
spellingShingle Speich, B
Von Niederhäusern, B
Blum, CA
Keiser, J
Schur, N
Fürst, T
Kasenda, B
Christ-Crain, M
Hemkens, LG
Pauli-Magnus, C
Schwenkglenks, M
Briel, M
Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
title Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
title_full Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
title_fullStr Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
title_full_unstemmed Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
title_short Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
title_sort retrospective assessment of resource use and costs in two investigator initiated randomized trials exemplified a comprehensive cost item list
work_keys_str_mv AT speichb retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT vonniederhausernb retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT blumca retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT keiserj retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT schurn retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT furstt retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT kasendab retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT christcrainm retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT hemkenslg retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT paulimagnusc retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT schwenkglenksm retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist
AT brielm retrospectiveassessmentofresourceuseandcostsintwoinvestigatorinitiatedrandomizedtrialsexemplifiedacomprehensivecostitemlist